Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Seiler

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Prostaglandins|January 1, 1997
[3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost bindingS M Seiler, C L Brassard, M E Federici, et al.
Biochemical and Biophysical Research Communications|December 16, 1991
Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitorS M Seiler, H J Goldenberg, I M Michel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2001
Tuberculin skin testing of physicians at a midwestern teaching hospital: a 6-year prospective studyD K Warren, K M Foley, L B Polish, et al.
Circulation Research|April 1, 1989
High molecular weight proteins purified from cardiac junctional sarcoplasmic reticulum vesicles are ryanodine-sensitive calcium channelsD P Rardon, D C Cefali, R D Mitchell, et al.
Biochemical Pharmacology|February 14, 1995
Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonistS M Seiler, M Peluso, I M Michel, et al.
Journal of Medicinal Chemistry|December 6, 1996
Development of potent thrombin receptor antagonist peptidesM S Bernatowicz, C E Klimas, K S Hartl, et al.
Molecular Pharmacology|January 1, 1996
Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonistsS M Seiler, M Peluso, J G Tuttle, et al.
Bioorganic & Medicinal Chemistry|August 1, 1995
Azetidin-2-one derivatives as inhibitors of thrombinW T Han, A K Trehan, J J Wright, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleedingW A Schumacher, T E Steinbacher, C L Heran, et al.
Circulation Research|July 1, 1990
Digestion of cardiac and skeletal muscle junctional sarcoplasmic reticulum vesicles with calpain II. Effects on the Ca2+ release channelD P Rardon, D C Cefali, R D Mitchell, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Prostaglandins|January 1, 1997
[3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost bindingS M Seiler, C L Brassard, M E Federici, et al.
Biochemical and Biophysical Research Communications|December 16, 1991
Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitorS M Seiler, H J Goldenberg, I M Michel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2001
Tuberculin skin testing of physicians at a midwestern teaching hospital: a 6-year prospective studyD K Warren, K M Foley, L B Polish, et al.
Circulation Research|April 1, 1989
High molecular weight proteins purified from cardiac junctional sarcoplasmic reticulum vesicles are ryanodine-sensitive calcium channelsD P Rardon, D C Cefali, R D Mitchell, et al.
Biochemical Pharmacology|February 14, 1995
Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonistS M Seiler, M Peluso, I M Michel, et al.
Journal of Medicinal Chemistry|December 6, 1996
Development of potent thrombin receptor antagonist peptidesM S Bernatowicz, C E Klimas, K S Hartl, et al.
Molecular Pharmacology|January 1, 1996
Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonistsS M Seiler, M Peluso, J G Tuttle, et al.
Bioorganic & Medicinal Chemistry|August 1, 1995
Azetidin-2-one derivatives as inhibitors of thrombinW T Han, A K Trehan, J J Wright, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleedingW A Schumacher, T E Steinbacher, C L Heran, et al.
Circulation Research|July 1, 1990
Digestion of cardiac and skeletal muscle junctional sarcoplasmic reticulum vesicles with calpain II. Effects on the Ca2+ release channelD P Rardon, D C Cefali, R D Mitchell, et al.
Pageof 4